Project Grant T32CA302559

Award Date 7/1/25
Completion Date 6/30/30
Dollars Obligated $178K
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $1,036,293 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the University of California, Los Angeles (UCLA) for their Neuro-Oncology Translational Research Training Program (NOTR-TP). The NOTR-TP is a multidisciplinary translational research program that aims to expand brain tumor research and clinical care by providing training and mentorship to 4 trainees - 1 predoctoral and 3 postdoctoral fellows,...
The University of Cincinnati is the recipient of a $383,491 Project Grant from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) to establish a Training Program in Basic and Translational Oncology. The goal of the 5-year program is to increase the number of researchers capable of bridging the divide between cancer biology research and clinical application, with a focus on cancer metabolism, tumor immunology, and translational cancer therapy. The program will provide...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $193,144 to The Trustees of Columbia University in the City of New York to support a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers. The 5-year program, running from September 1, 2024 to August 31, 2029, aims to train the next generation of GI cancer researchers across basic science, translational, clinical, epidemiological, and...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $2,186,372 Project Grant (CFDA 93.396 - Cancer Biology Research) to the University of California, Irvine (UCI) to support a 5-year research program investigating "tipping points" in cancer initiation and progression. The program will leverage mouse models to study stochastic, non-genetic cellular transitions and cell-cell interactions that drive the progression from pre-malignant to...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) awarded a $388,712 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Dana-Farber Cancer Institute (DFCI) in Boston, MA. The "Young Empowered Scientists for Continued Research Engagement (YES for CURE)" program aims to increase participation and retention of underrepresented minority students in cancer-related STEM fields. The multi-year program will provide high school...
This National Cancer Institute (NCI) Project Grant award under CFDA 93.395 "Cancer Treatment Research" provides $196,267 in funding to the University of California, Irvine (UCI) to advance novel cancer prevention and therapeutic strategies across NCI's clinical trial networks. The award will support the Principal Investigator's leadership roles on key NCI committees, completion of an ongoing Phase III clinical trial focused on preventing colorectal adenomas in a racially/ethnically...
The National Cancer Institute (NCI) awarded a $118,687 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the University of Florida. The grant will fund the "THE FLORIDA SUMMER TRAINING IN RESEARCH AND ONCOLOGY FOR THE NEXT GENERATION OF RESEARCHERS (STRONGER) PROGRAM" which aims to provide 8 undergraduate students from non-R1 universities, including Historically Black Colleges and Universities and Hispanic-Serving Institutions, with hands-on cancer...
The National Cancer Institute (NCI) awarded a $512,974 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the Sloan-Kettering Institute for Cancer Research, a non-profit cancer research institution located in New York City. The grant, effective August 13, 2024 through July 31, 2029, will fund research to develop advanced predictive models for non-small cell lung cancer (NSCLC) outcomes using a combination of real-world data sources, including tumor genomic...
The National Cancer Institute (NCI) awarded a $411,824 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Trustees of Indiana University (Indiana University Indianapolis) to establish the Surgical Oncology Research Training at Indiana (SORTI) program. The SORTI program will provide a two-year intensive research training experience for surgical residents, creating a pipeline of successful, independently funded surgeon-scientists in surgical oncology. The program...
This federal Project Grant award for $166,428 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support a new T32 predoctoral training program at Stanford University to prepare the next generation of multi-disciplinary cancer researchers. The program, titled "Genetic and Environmental Basis of Cancer Risk and Disparities (GECARD)," will provide integrative training across fields like epidemiology, biostatistics, genetics, environmental health, and...

The National Cancer Institute (NCI) awarded a $178,444 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the University of California, Los Angeles (UCLA) for the "UCLA SURGEON-SCIENTIST BASIC CANCER RESEARCH TRAINING PROGRAM (UCLA SURGEON-SCIENTIST BCRTP)". The program aims to provide rigorous curriculum and mentored research experiences to exceptional surgical residents dedicated to advancing cancer research and treatment innovation. The program will support two surgical resident trainees per year from 2025 to 2030, leveraging UCLA's extensive resources and a network of NIH-funded faculty to deliver a personalized training experience. The program seeks to address the critical gap in the declining number of surgeon-scientists and prepare trainees to compete for transdisciplinary NIH funding, ultimately driving future advancements in cancer research, technology development, and patient care.

Generated 8/5/25, 5:17 AM